Shelly Loewenstein

Dr. Shelly Loewenstein


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
OKOlga Kersy
Olga Kersy
SLShelly Loewenstein
Shelly Loewenstein
NLNir Lubezky
Nir Lubezky
OSOsnat Sher
Osnat Sher
NSNatalie B. Simon
Natalie B. Simon
GLGuy Lahat
Guy Lahat
The peritoneal cavity, especially the omentum, is a common site for gastric cancer metastasis, representing advanced disease stage and poor prognosis. Here, we studied the effects of omental tissue on gastric cancer tumor progression in vitro and in vivo. Utilizing in vitro models, we found that omental tissue secreted factors increased gastric cancer cellular growth (by 30–67%, P < 0.05), motility (>8-fold, P < 0.05), invasiveness (>7-fold, P < 0.05) and chemoresistance to platinum-based chemotherapeutic agents (>1.2-fold for oxaliplatin and >1.6-fold for cisplatin, P < 0.05). Using a robust proteomic approach, we identified numerous molecules secreted into the omental tissue conditioned medium (CM) which may promote gastric cancer cellular aggressiveness (i.e., IL-6, IL-8, MMP9, FN1, and CXCL-5). Next, an in vivo xenograft mouse model showed an increased human gastric adenocarcinoma tumor volume of cells co-cultured with human omental tissue secreted factors; 1.6 ± 0.55 vs. 0.3 ± 0.19 cm3 (P < 0.001), as well as increased angiogenesis. Finally, exosomes were isolated from human omental tissue CM of gastric cancer patients. These exosomes were taken up by gastric cancer cells enhancing their growth (>8-fold, P < 0.01) and invasiveness (>8-fold, P < 0.001). Proteomic analysis of the content of these exosomes identified several established cancer- related proteins (i.e., IL-6, IL-8, ICAM-1, CCl2, and OSM). Taken together, our findings imply that the omentum play an active role in gastric cancer metastasis. The data also describe specific cytokines that are involved in this cross talk, and that omental tissue- derived exosomes may contribute to these unique cellular interactions with gastric cancer cells. Further studies aimed at understanding the biology of gastric cancer intra peritoneal spread are warranted. Hopefully, such data will enable to develop future novel therapeutic strategies for the treatment of metastatic gastric cancer.

20 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VFValerya Feygenzon
Valerya Feygenzon
SLShelly Loewenstein
Shelly Loewenstein
NLNir Lubezky
Nir Lubezky
MPMetsada Pasmanic-Chor
Metsada Pasmanic-Chor
OSOsnat Sher
Osnat Sher
GLGuy Lahat
Guy Lahat
Pancreatic cancer is a common cause of cancer-related mortality. Omental spread is frequent and usually represents an ominous event, leading to patient death. Omental metastasis has been studied in ovarian cancer, but data on its role in pancreatic cancer are relatively scarce and the molecular biology of this process has yet to be explored. We prepared tissue explants from human omental fat, and used conditioned medium from the explants for various in vitro and in vivo experiments designed to evaluate pancreatic cancer development, growth, and survival. Mass spectrometry identified the fat secretome, and mRNA array identified specific fat-induced molecular alternations in tumor cells. Omental fat increased pancreatic cancer cellular growth, migration, invasion, and chemoresistance. We identified diverse potential molecules secreted by the omentum, which are associated with various pro-tumorigenic biological processes. Our mRNA array identified specific omental-induced molecular alternations that are associated with cancer progression and metastasis. Omental fat increased the expression of transcription factors, mRNA of extracellular matrix proteins, and adhesion molecules. In support with our in vitro data, in vivo experiments demonstrated an increased pancreatic cancer tumor growth rate of PANC-1 cells co-cultured for 24 hours with human omental fat conditioned medium. Our results provide novel data on the role of omental tissue in omental metastases of pancreatic cancer. They imply that omental fat secreted factors induce cellular reprogramming of pancreatic cancer cells, resulting in increased tumor aggressiveness. Understanding the mechanisms of omental metastases may enable us to discover new potential targets for therapy.

15 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
TKTalya Kalfon
Talya Kalfon
SLShelly Loewenstein
Shelly Loewenstein
FGFabian Gerstenhaber
Fabian Gerstenhaber
SLStav Leibou
Stav Leibou
HGHen Geller
Hen Geller
GLGuy Lahat
Guy Lahat
Angiogenesis is an important control point of gastric cancer (GC) progression and metastasis. Angiopoietin-2 (ANG2) is a key driver of tumor angiogenesis and metastasis, and it has been identified in primary GC tissues. Extracellular vesicles (EVs) play an important role in mediating intercellular communication through the transfer of proteins between cells. However, the expression of ANG2 in GC-EVs has never been reported. Here, we characterized the EV-mediated crosstalk between GC and endothelial cells (ECs), with particular focus on the role of ANG2. We first demonstrate that ANG2 is expressed in GC primary and metastatic tissues. We then isolated EVs from two different GC cell lines and showed that these EVs enhance EC proliferation, migration, invasion, and tube formation in vitro and in vivo. Using an angiogenesis protein array, we showed that GC-EVs contain high levels of proangiogenic proteins, including ANG2. Lastly, using Lenti viral ANG2-shRNA, we demonstrated that the proangiogenic effects of the GC-EVs were mediated by ANG2 through the activation of the PI3K/Akt signal transduction pathway. Our data suggest a new mechanism via which GC cells induce angiogenesis. This knowledge may be utilized to develop new therapies in gastric cancer.

1 March 2008 in Antiviral Research
Verified
Journal Article
Closed access
ATAlla Trahtenherts
Alla Trahtenherts
MGM Galtanamy
M Galtanamy
RZRomy Zemel
Romy Zemel
LBLarisa Bachmatov
Larisa Bachmatov
SLShelly Loewenstein
Shelly Loewenstein
Itai BenharItai Benhar
Itai Benhar

1 December 2016 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
SLShelly Loewenstein
Shelly Loewenstein
NLNir Lubezky
Nir Lubezky
ENEran Nizri
Eran Nizri
MZMeir Zemel
Meir Zemel
YLYishai Levin
Yishai Levin
GLGuy Lahat
Guy Lahat
Previous data demonstrated that high retroperitoneal visceral fat content increases retroperitoneal soft-tissue sarcoma (RSTS) local recurrence and patients' mortality. Most RSTS tumors initiate and recur within visceral fat. The objective of the current study was to evaluate potential paracrine effects of visceral fat on RSTS. A xenograft model was used to evaluate in vivo effects of human visceral fat on STS growth. Tissue explants were prepared from visceral fat, and their conditioned medium (CM) was utilized for various in vitro experiments designed to evaluate growth, survival, migration, and invasion of STS and endothelial cells. Visceral fat–secreted protumorigenic factors were identified by mass spectrometry. The in vivo experiments demonstrated a significant increase in STS tumor growth rate when SK-LMS-1 leiomyosarcoma cells were colocalized with human visceral fat compared with subcutaneous injection of cancer cells only. The in vitro model demonstrated that visceral fat CM increased STS cellular growth and reduced doxorubicin-induced apoptosis. Visceral fat also enhanced STS cellular migration and invasion. In addition, visceral fat CM significantly increased endothelial cell tube formation, suggesting its role as a proangiogenic factor in the STS tumor microenvironment (TME). Using a robust proteomic approach, liquid chromatography and tandem mass spectrometry resolved various molecules within the visceral fat CM, of which a subset was associated with protumorigenic biologic processes. These results suggest that visceral fat directly interacts with STS cells by secreting specific adipokines into the TME, thus augmenting STS tumor cell proliferation and invasiveness. Fat-induced STS molecular deregulations should be studied to identify new potential prognostic and therapeutic targets. Implications: Visceral fat induces protumorigenic effects, in STS, through various secreted factors that should be investigated to improve our understanding of adipose–cancer cell interactions. Mol Cancer Res; 14(12); 1254–65. ©2016 AACR.

Verified
Open access
PDF file
SLShelly Loewenstein
Shelly Loewenstein
FGFabian Gerstenhaber
Fabian Gerstenhaber
SMSapir Milshtain
Sapir Milshtain
SLStav Leibou
Stav Leibou
OROmri Rahamimov
Omri Rahamimov
GLGuy Lahat
Guy Lahat
Background Peritoneal mesothelial cells play a critical role in shaping the peritoneal tumor microenvironment and are increasingly recognized as active regulators of angiogenesis in cancers that metastasize to the peritoneum, including gastrointestinal (GI) and ovarian malignancies. Through complex interactions with tumor and stromal cells, peritoneal mesothelial cells contribute to the establishment of a pre-metastatic niche in the peritoneal cavity. Extracellular vesicles (EVs), nanosized vesicles secreted by most cell types, mediate intercellular communication by transferring bioactive molecules such as proteins, lipids, and nucleic acids. While tumor-derived EVs have been extensively studied in cancer progression, the role of mesothelial cells-derived EVs in regulating endothelial function and angiogenesis remains largely unexplored. Methods EVs were isolated from conditioned media of mesothelial cells and characterized before functional assays. Their effects on endothelial cell behavior were assessed using proliferation, migration, and invasion assays, as well as Matrigel-based tube formation and in vivo angiogenesis plug models. A proteome profiler angiogenesis array was used to identify enriched pro-angiogenic mediators. Mechanistic studies were conducted using lentiviral knockdown and overexpression strategies. Results Endothelial cells efficiently internalized mesothelial cells-derived EVs, leading to significant increases in proliferation, migration, invasion, and angiogenesis in vitro and in vivo. Proteomic profiling identified 43 angiogenic regulators within mesothelial cells-derived EVs, with angiopoietin-2 (ANG2) emerging as a key effector. Functional analyses demonstrated that mesothelial cells-derived EVs-induced angiogenesis was mediated through ANG2-TIE2 signaling, with subsequent activation of PI3K, Akt, and ERK1/2 pathways. Importantly, inhibition of ANG2 markedly reduced these angiogenic effects. Conclusions This work establishes that EVs secreted by mesothelial cells promote angiogenesis by reprogramming endothelial cells through ANG2-dependent signaling. These findings uncover a novel mechanism of mesothelial-endothelial communication and highlight the ANG2 pathway as a promising therapeutic target in advanced GI cancers with peritoneal metastasis.